114468-04-1

Basic information

• Product Name: 3-BroMo-5-(difluoroMethyl)pyridine, 97%
• Synonyms: 3-BroMo-5-(difluoroMethyl)pyridine, 97%
• CAS NO: 114468-04-1
• Molecular Formula: C6H4BrF2N
• Molecular Weight: 208.0034664
• Mol File: 114468-04-1.mol

Chemical Properties

• Melting Point: 35-38℃
• Flash Point: 110℃
• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-BroMo-5-(difluoroMethyl)pyridine, 97%(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BroMo-5-(difluoroMethyl)pyridine, 97%(114468-04-1)
• EPA Substance Registry System: 3-BroMo-5-(difluoroMethyl)pyridine, 97%(114468-04-1)

Safety Data

• Hazard Codes: Xi
• Statements: 36
• Safety Statements: 39
• WGK Germany: 3
• Hazardous Substances Data: 114468-04-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-Bromo-5-(difluoromethyl)pyridine, 97% is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with improved therapeutic properties and reduced side effects.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Bromo-5-(difluoromethyl)pyridine, 97% serves as a crucial building block for the creation of novel pesticides and herbicides. Its incorporation into these products can enhance their effectiveness and selectivity, leading to better crop protection and reduced environmental impact.
Used in Advanced Materials:
3-Bromo-5-(difluoromethyl)pyridine, 97% is utilized as a precursor in the development of advanced materials with unique properties. These materials can be employed in various applications, such as electronics, energy storage, and nanotechnology, where their specific characteristics provide advantages over traditional materials.
Used in Research Applications:
As a high-purity chemical compound, 3-Bromo-5-(difluoromethyl)pyridine, 97% is an essential tool for researchers in academia and industry. It enables the exploration of new chemical reactions, the synthesis of novel compounds, and the investigation of structure-property relationships in various fields of chemistry and materials science.

Upstream product

• 113118-81-3 5-bromopyridine-3-carbaldehyde 
• 500-22-1 3-pyridinecarboxaldehyde 
• 76541-44-1 3-(difluoromethyl)pyridine 

Relevant articles and documents

FLUOROALKYL-OXADIAZOLES AND USES THEREOF

Provided herein are compounds identified as inhibitors of HDAC6 activity that can be used to treat various diseases and disorders.

ALDOSTERONE SYNTHASE INHIBITORS

The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, wherein R1, R2 and R3, are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

5-SUBSTITUTED INDAZOLE-3-CARBOXAMIDES AND PREPARATION AND USE THEREOF

Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease, lung disease, fibrotic disorders, cartilage (chondral) defects, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, and neurological conditions/disorders/diseases linked to overexpression of DYRK1A.

Compounds and their use as BACE Inhibitors

The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.

Syntheses of New Aromatic Compounds with Fluorinated Side Chains and their Chemical Reactivity

The syntheses of a wide range of aromatic compounds of the type p-Y-C6H4CF2X(4-13) are described, and the chemical behavior of these compounds as a function of substituent Y is investigated .Analogously the pyridine derivatives 15, 17, and 18 were synthesized and characterized.From a correlation of the 19F-NMR data of these compounds with the Hammett constant of Y, participation of C-F ?-back-donation is seen as the cause for an observed shift of the 19F signals to lower field.